Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
Oncotarget|December 31, 2015
Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancerFeng Su, Shilin Zhu, Jinlan Ruan, et al.Stem Cells (Dayton, Ohio)|February 6, 2010
Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisitedFrank Pajonk, Erina Vlashi, William H McBrideNeurosurgery Clinics of North America|March 30, 2021
Pediatric Gliomas: Molecular Landscape and Emerging TargetsSophie M Peeters, Yagmur Muftuoglu, Brian Na, et al.Journal of Cellular Biochemistry|July 23, 2009
Radiation responses of cancer stem cellsErina Vlashi, William H McBride, Frank PajonkThe Prostate|September 21, 2011
Radioresistance of prostate cancer cells with low proteasome activityLorenza Della Donna, Chann Lagadec, Frank PajonkNeoplasia (New York, N.Y.)|January 16, 2007
The proteasome inhibitor MG-132 protects hypoxic SiHa cervical carcinoma cells after cyclic hypoxia/reoxygenation from ionizing radiationFrank Pajonk, Thorsten Grumann, William H McBridePlos One|April 6, 2012
Oxygen levels do not determine radiation survival of breast cancer stem cellsChann Lagadec, Carmen Dekmezian, Lucile Bauché, et al.Journal of the National Cancer Institute|December 21, 2006
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiationTiffany M Phillips, William H McBride, Frank PajonkCancer Research|June 3, 2005
Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cellsFrank Pajonk, Arndt van Ophoven, William H McBrideStrahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 19, 2002
Vitiligo at the sites of irradiation in a patient with Hodgkin's diseaseFrank Pajonk, Christian Weissenberger, Gerlo Witucki, et al.Pageof 9